Terc-/- mice displayed reduced cancer incidence as well as premature aging [30] and third generation Terc-/- mice (G3 Terc-/- mice) showed severely impaired left ventricular function, increased myocyte size and decreased angiogenic potential [31]. This evidence concerns the gene TERC and cancer.